Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
10/10/1989 | US4873342 Anti-amnesic agent |
10/10/1989 | US4873317 Method of separating or purifying proteins and other biopolymers |
10/10/1989 | US4873312 Unfolding in denaturing solution; diafiltration |
10/10/1989 | US4873235 Benzofused lactams as antihypertensives |
10/10/1989 | US4873222 Placenta-derived anticoagulating substance |
10/10/1989 | US4873083 To improve blood flow and oxygenation; injecting ethylene oxide-propylene oxide copolymer solution |
10/10/1989 | CA1262238A1 Human monoclonal antibodies against bacterial toxins |
10/05/1989 | WO1989009277A1 Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression |
10/05/1989 | WO1989009271A1 Recombinant retroviruses |
10/05/1989 | WO1989009268A1 Production of insulin-like growth factor binding protein |
10/05/1989 | WO1989009266A1 Novel human tissue plasminogen activator variants and processes |
10/05/1989 | WO1989009234A1 Therapeutic murine monoclonal antibody |
10/05/1989 | WO1989009232A1 Neuropeptide antagonists |
10/05/1989 | WO1989009231A1 Therapeutic peptides |
10/05/1989 | WO1989009230A1 Therapeutic peptides |
10/05/1989 | WO1989009229A1 Treatment of hiv viremic patients with thymopentin |
10/05/1989 | WO1989009227A2 Pf10 to pf19 peptides of an hiv retrovirus, process for synthetizing said peptides and their use, in particular for diagnosis |
10/05/1989 | WO1989009226A1 Peptides |
10/05/1989 | WO1989009225A1 Nerve growth factor peptides |
10/05/1989 | WO1989009220A1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
10/05/1989 | WO1989009065A1 Large-scale production of bovine leukocyte interferon |
10/05/1989 | WO1989009062A1 Combination therapy of il-2 and dtic for the treatment of melanoma |
10/05/1989 | WO1989009061A1 Improved cytotoxic therapy |
10/05/1989 | WO1989009060A1 Hematopoietic colony-stimulating factors improve the lipoprotein cholesterol profile |
10/04/1989 | EP0335804A1 Process for the preparation of an antilymphocyte serum by immunization of animals with a human T lymphoblast clone and antilymphocyte serum obtained therefrom |
10/04/1989 | EP0335726A2 Use of thymopentin and derivatives in treatment of HIV viremic patients |
10/04/1989 | EP0335662A1 Peptides |
10/04/1989 | EP0335637A2 Nerve growth factor peptides |
10/04/1989 | EP0335627A2 Use of a thromboxane antagonist in cyclosporin A-induced nephrotoxicity |
10/04/1989 | EP0335597A2 Use of a polypeptide in the preparation of a composition for the treatment of pancreatitis |
10/04/1989 | EP0335554A2 Cosmetic composition |
10/04/1989 | EP0335550A1 Biologically active material characterised by catabolic activity generally associated with cachexia-inducing tumours, preparations, production and uses thereof |
10/04/1989 | EP0335483A2 Condensed imidazole derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them. |
10/04/1989 | EP0335476A2 Recombinant methods for the production of ricin a, ricin b, ricin or diphtheria toxin (dt)a or ab' fragment, suitable hosts and vectors therefor, and conjugates comprising ricin toxin a chain or diphtheria toxin |
10/04/1989 | EP0335426A2 Compositions and process for protecting T lymphocytes against the etiological agent of lymphadenopathy and acquired immunodepression syndrom |
10/04/1989 | EP0335423A2 Modified human G-CSF |
10/04/1989 | EP0335243A2 Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression |
10/04/1989 | EP0335133A2 Drug delivery using pulmonary surfactant fo facilitate absorption |
10/04/1989 | EP0334958A1 Monoclonal antibodies |
10/04/1989 | CN1036036A Cell-associated glucosyltransferase, antibody thereto, and dental caries prophylactic composition contg. said antibody as effective component |
10/03/1989 | US4871872 2-[(2-aminoacetyl)amino]acetamide derivatives |
10/03/1989 | US4871842 Angiotensin converting enzyme inhibitor, hypotensive agents, c ardiovascular disorders |
10/03/1989 | US4871835 Analogs of hGH having antagonistic activity, and uses thereof |
10/03/1989 | US4871770 Method of inhibiting the activity of peroxidases and stimulating tumor growth |
10/03/1989 | US4871768 Dietary supplement utilizing ω-3/medium chain trigylceride mixtures |
10/03/1989 | US4871718 Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair |
10/03/1989 | US4871717 Peptides |
10/03/1989 | US4871670 Dna transfer vector |
10/03/1989 | US4871663 Exporession vector for human TnF |
10/03/1989 | US4871540 Process for producing a biologically active substance and compositions containing the same |
10/03/1989 | US4871538 Injectable; anticarcinogenic agents, viricides |
10/03/1989 | US4871350 Methods and compositions for preventing secondary cataracts |
09/28/1989 | DE3808456A1 Polypeptides for use in spasmolytic pharmaceuticals or as neurotransmitters |
09/27/1989 | EP0334685A2 Bradykinin analogues, their synthesis and their use in therapy |
09/27/1989 | EP0334632A2 Novel antibiotic |
09/27/1989 | EP0334467A2 Cell-associated glucosyltransferase, an antibody thereto, and a dental caries prophylactic composition containing said antibody |
09/27/1989 | EP0334301A1 Recombinant retroviruses |
09/27/1989 | EP0334264A2 Pharmaceutical compositions for treating tardive dyskinesia employing an ace inhibitor |
09/27/1989 | EP0334244A2 Bradykinin Antagonist Peptides |
09/27/1989 | EP0334165A2 Monoclonal antibodies |
09/27/1989 | EP0333769A1 Combinations of renal vasodilators and alpha 1-adrenergic or ganglionic blocking agents for treating diseases |
09/27/1989 | CN1035773A Composition inducing binding |
09/26/1989 | USRE33071 Complexing |
09/26/1989 | US4870163 Purification by multistage adsorption |
09/26/1989 | US4870160 Polypeptides with laminin activity |
09/26/1989 | US4870067 Oxytocins and antigestagens in combination for induction of birth |
09/26/1989 | US4870056 Deterrents of alcohol abuse |
09/26/1989 | US4870054 Treatment for osteoporosis using GRF or a biologically active analog thereof |
09/26/1989 | US4870053 Antiallergy acyl glycoprotein from klebsiella |
09/26/1989 | US4870002 3-amino-l-tyrosine |
09/26/1989 | US4869903 Human innumedeficiency virus; single-chain ribosome inactivating protein |
09/26/1989 | EP0329693A4 Human pancreatic secretory trypsin inhibitors produced by recombinant dna methods and processes for the production of same. |
09/26/1989 | CA1262016A1 Anticancer agent |
09/26/1989 | CA1262015A1 Acylated sugar derivatives, processes for their manufacture, and their use |
09/26/1989 | CA1262013A1 Substituted dipeptide amides 4 |
09/26/1989 | CA1262010A1 Amino thiol peptides |
09/26/1989 | CA1261549A1 Polypeptide cartilage-inducing factors found in bone |
09/26/1989 | CA1261548A1 Cyclic octapeptides and pharmaceutical preparations thereof, as well as processes for their manufacture, and their use |
09/26/1989 | CA1261547A1 Peptide-aldehydes, process for the preparation thereof and pharmaceutical compositions containing the same |
09/26/1989 | CA1261546A1 N - (acyldipeptidyl) - aminoglycols |
09/26/1989 | CA1261332A1 Ester substituted aminoalkanoylureido amino and imino acid and ester compounds |
09/26/1989 | CA1261259A1 Wound healing agents |
09/26/1989 | CA1261258A1 Angiogenic factor and method for producing angiogenesis |
09/26/1989 | CA1260831A1 Insoluble medicament for a local administration in a human or animal ear |
09/26/1989 | CA1260828A1 Therapeutic and prophylactic agent for gastrointestinal ulcers |
09/26/1989 | CA1260650A1 Process for preparing malleable collagen and product thereof |
09/26/1989 | CA1260390A1 Anti bacterial food compositions for animals and process for preparing them |
09/26/1989 | CA1260389A1 Human plasma, plasma fractions, and compositions thereof substantially free of infectious viruses, bacteria and retroviruses |
09/26/1989 | CA1259923A1 Physiologically active compositions |
09/26/1989 | CA1259920A1 Immunotoxin and method of making |
09/26/1989 | CA1259914A1 Methods of bone repair using collagen |
09/26/1989 | CA1259913A1 Preparation for rehydrating monogastric animals including human beings, suffering from diarrhoea and use thereof |
09/21/1989 | WO1989008711A1 Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human mucin and with synthetic carbohydrate-carrier conjugates |
09/21/1989 | WO1989008709A1 Biologically active material characterised by catabolic activity generally associated with cachexia-inducing tumours, preparations, production and uses thereof |
09/21/1989 | WO1989008667A1 Recombinant igf binding protein (ibp-1) |
09/21/1989 | WO1989008666A1 Heparin-binding proteins, dna cuding for them, processes for producing them as well as therapeutic preparations containing them |
09/21/1989 | WO1989008665A1 NOVEL NEUTROPHIL CHEMOTACTIC FACTOR, CLONED cDNA AND MONOCLONAL ANTIBODIES THERETO |
09/21/1989 | WO1989008663A1 Synthetic peptides derived from the alpha-subunit of human glycoprotein hormones |
09/21/1989 | WO1989008662A1 General cancer-associated scm-recognition factor, preparation and method of use |
09/21/1989 | WO1989008661A1 Human heat shock factor |